ClinicalTrials.gg
Drug

Degarelix clinical trials

Also written Firmagon, FE200486 and ASP3550.

studies test it
81
open now
4
in phase 3
29
first study started
2001

How each study uses degarelix is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the degarelix studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
24 Dec 2008 · FIRMAGON · NDA 022201 (FDA, Drugs@FDA)
European Union
17 Feb 2009 · Firmagon · EMEA/H/C/000986 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Degarelix
68
Degarelix acetate
5
Degarelix 20 mg
2

Brand

Firmagon
36

Development codes

FE200486
26
ASP3550
4

Studies by the year they started

80 studies that test it; most in 2012 (11)

Studies that test degarelix, by start year
YearStudies
20012
20023
20031
20042
20053
20062
20074
20082
20097
20105
20112
201211
20134
20143
20157
20162
20175
20181
20191
20204
20211
20221
20234
20242
20261

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
43
Phase 3
29
Phase 4
5
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 40 · Other 41

Ferring Pharmaceuticals (37) · Memorial Sloan Kettering Cancer Center (6) · Astellas Pharma Inc (3) · Centre for Endocrinology and Reproductive Medicine, Italy (2) · British Columbia Cancer Agency (2) · Rabin Medical Center (2) · University Health Network, Toronto (2) · The University of Texas Health Science Center, Houston (2)

Often tested with

Tested in the same studies.

Leuprolide (9) · Triptorelin (7) · Goserelin (6) · Bicalutamide (5) · Docetaxel (4) · Darolutamide (3) · Abiraterone Acetate (3) · Abiraterone (3)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test degarelix, phase 3 first.

Studies

Open first, then newest update. How each study uses degarelix is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 81

See all 81 studies that test degarelix →

Given beside what is tested · 28 — degarelix is usual care or a partner of the new treatment

Showing 20 of 28.

As the comparator · 5 — what is tested is compared with degarelix

Codes

What other systems call degarelix · ClinicalTrials.gg INT004362

  • UNII (FDA) SX0XJI3A11DEGARELIXConfirmed FDA, Wikidata
  • RxNorm 475230Confirmed FDA, Wikidata
  • Wikidata Q1182795degarelixConfirmed FDA, Wikidata
  • NCI Thesaurus C48385DegarelixConfirmed FDA, Wikidata
  • DrugBank DB06699One source Wikidata

Also registered as degarelix acetate (UNII I18S89P20R · RxNorm 835863).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.